Literature DB >> 19731804

Germline transcription: a key regulator of accessibility and recombination.

Iratxe Abarrategui1, Michael S Krangel.   

Abstract

The developmental control of V(D)J recombination is imposed at the level of chromatin accessibility of recombination signal sequences (RSSs) to the recombinase machinery. Cis-acting transcriptional regulatory elements such as promoters and enhancers play a central role in the control of accessibility in vivo. However, the molecular mechanisms by which these elements influence accessibility are still under investigation. Although accessibility for V(D)J recombination is usually accompanied by germline transcription at antigen receptor loci, the functional significance of this transcription in directing RSS accessibility has been elusive. In this chapter, we review past studies outlining the complex relationship between V(D)J recombination and transcription as well as our current understanding on how chromatin structure is regulated during gene expression. We then summarize recent work that directly addresses the functional role of transcription in V(D)J recombination.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19731804     DOI: 10.1007/978-1-4419-0296-2_8

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  22 in total

1.  DNA double-strand breaks relieve USF-mediated repression of Dβ2 germline transcription in developing thymocytes.

Authors:  Jennifer L Stone; Ruth E McMillan; David A Skaar; Justin M Bradshaw; Randy L Jirtle; Michael L Sikes
Journal:  J Immunol       Date:  2012-01-27       Impact factor: 5.422

2.  Epigenetic modifications of the VH region after DJH recombination in Pro-B cells.

Authors:  Yanying Dong; Caijun Wu; Xiaohui Zhao; Ping Zhang; Hua Zhang; Mingzhe Zheng; Shichang Li; Junna Jiao; Xiaozhuo Yu; Zhuangwei Lv; Yanhong Ji
Journal:  Immunology       Date:  2017-06-23       Impact factor: 7.397

3.  TRIM28 mediates chromatin modifications at the TCRα enhancer and regulates the development of T and natural killer T cells.

Authors:  Xiao-Fei Zhou; Jiayi Yu; Mikyoung Chang; Minying Zhang; Dapeng Zhou; Florence Cammas; Shao-Cong Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-19       Impact factor: 11.205

Review 4.  Transcriptional and epigenetic networks of helper T and innate lymphoid cells.

Authors:  Han-Yu Shih; Giuseppe Sciumè; Amanda C Poholek; Golnaz Vahedi; Kiyoshi Hirahara; Alejandro V Villarino; Michael Bonelli; Remy Bosselut; Yuka Kanno; Stefan A Muljo; John J O'Shea
Journal:  Immunol Rev       Date:  2014-09       Impact factor: 12.988

5.  The zebrafish IgH locus contains multiple transcriptional regulatory regions.

Authors:  N Danilova; H L Saunders; K K Ellestad; B G Magor
Journal:  Dev Comp Immunol       Date:  2010-11-11       Impact factor: 3.636

6.  Noncore RAG1 regions promote Vβ rearrangements and αβ T cell development by overcoming inherent inefficiency of Vβ recombination signal sequences.

Authors:  Julie E Horowitz; Craig H Bassing
Journal:  J Immunol       Date:  2014-01-10       Impact factor: 5.422

7.  Evidence for Ig Light Chain Isotype Exclusion in Shark B Lymphocytes Suggests Ordered Mechanisms.

Authors:  Anna Iacoangeli; Anita Lui; Ashley Haines; Yuko Ohta; Martin Flajnik; Ellen Hsu
Journal:  J Immunol       Date:  2017-07-31       Impact factor: 5.422

8.  Ectopic T cell receptor-α locus control region activity in B cells is suppressed by direct linkage to two flanking genes at once.

Authors:  Stefan Knirr; Janette Gomos-Klein; Blanca E Andino; Faith Harrow; Karl F Erhard; Damian Kovalovsky; Derek B Sant'Angelo; Benjamin D Ortiz
Journal:  PLoS One       Date:  2010-11-22       Impact factor: 3.240

9.  Epigenetic regulation of antigen receptor gene rearrangement.

Authors:  Salvatore Spicuglia; Joaquin Zacarias-Cabeza; Aleksandra Pekowska; Pierre Ferrier
Journal:  F1000 Biol Rep       Date:  2010-03-25

Review 10.  Assembly and Expression of Shark Ig Genes.

Authors:  Ellen Hsu
Journal:  J Immunol       Date:  2016-05-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.